Affimed (AFMD) Misses Q2 EPS by 1c; CMO Marschner to Resign

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. LRCX
8. MRK
9. LVS
10. CSX

Go back to Affimed (AFMD) Misses Q2 EPS by 1c; CMO Marschner to Resign

Leerink Partners Downgrades Affimed Therapeutics (AFMD) to Market Perform

August 12, 2016 7:41 AM EDT

Leerink Partners downgraded Affimed Therapeutics (NASDAQ: AFMD) from Outperform to Market Perform with a price target of $3.00 (from $8.00).

Analyst Michael Schmidt commented, "We are downgrading shares of AFMD to Market Perform, given that the company's two clinical stage product candidates are... More